These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12113608)

  • 1. Laudanosine, an atracurium and cisatracurium metabolite.
    Fodale V; Santamaria LB
    Eur J Anaesthesiol; 2002 Jul; 19(7):466-73. PubMed ID: 12113608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite.
    Fodale V; Santamaria LB
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):780; 780-1. PubMed ID: 12803601
    [No Abstract]   [Full Text] [Related]  

  • 3. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine.
    Chiodini F; Charpantier E; Muller D; Tassonyi E; Fuchs-Buder T; Bertrand D
    Anesthesiology; 2001 Apr; 94(4):643-51. PubMed ID: 11379686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laudanosine (a metabolite of atracurium) increases the minimum alveolar concentration of halothane in rabbits.
    Shi WZ; Fahey MR; Fisher DM; Miller RD; Canfell C; Eger EI
    Anesthesiology; 1985 Dec; 63(6):584-8. PubMed ID: 2932981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma laudanosine levels in patients given atracurium during liver transplantation.
    Lawhead RG; Matsumi M; Peters KR; Landers DF; Becker GL; Earl RA
    Anesth Analg; 1993 Mar; 76(3):569-73. PubMed ID: 8452269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atracurium decay and the formation of laudanosine in humans.
    Nigrovic V; Fox JL
    Anesthesiology; 1991 Mar; 74(3):446-54. PubMed ID: 2001023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Schmith VD; Belmont MR; Abalos A; Kisor DF; Savarese JJ
    Anesthesiology; 1996 Feb; 84(2):300-8. PubMed ID: 8602660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.
    Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC
    Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism and pharmacokinetics of atracurium].
    Colin JN; Singlas E
    Ann Fr Anesth Reanim; 1985; 4(6):465-70. PubMed ID: 2936284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cisatracurium in critical care: a review of the literature.
    Szakmany T; Woodhouse T
    Minerva Anestesiol; 2015 Apr; 81(4):450-60. PubMed ID: 24721895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
    Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
    Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuromuscular blocking agents on excitatory transmission and gamma-aminobutyric acidA-mediated inhibition in the rat hippocampal slice.
    Chiodini FC; Tassonyi E; Fuchs-Buder T; Fathi M; Bertrand D; Muller D
    Anesthesiology; 1998 Apr; 88(4):1003-13. PubMed ID: 9579510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal failure on laudanosine excretion in man.
    Fahey MR; Rupp SM; Canfell C; Fisher DM; Miller RD; Sharma M; Castagnoli K; Hennis PJ
    Br J Anaesth; 1985 Nov; 57(11):1049-51. PubMed ID: 3840380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of cisatracurium besilate.
    Kisor DF; Schmith VD
    Clin Pharmacokinet; 1999 Jan; 36(1):27-40. PubMed ID: 9989341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
    Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P
    Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
    Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ
    Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat brain synaptosomal plasma membrane achieved by atracurium and its metabolite laudanosine.
    Kamper EF; Siafaka J; Stavridis J
    Intensive Care Med; 1998 May; 24(5):519-25. PubMed ID: 9660270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.